190 related articles for article (PubMed ID: 22306336)
1. Sustained release micellar carrier systems for iontophoretic transport of dexamethasone across human sclera.
Chopra P; Hao J; Li SK
J Control Release; 2012 May; 160(1):96-104. PubMed ID: 22306336
[TBL] [Abstract][Full Text] [Related]
2. Influence of drug lipophilicity on drug release from sclera after iontophoretic delivery of mixed micellar carrier system to human sclera.
Chopra P; Hao J; Li SK
J Pharm Sci; 2013 Feb; 102(2):480-8. PubMed ID: 23150488
[TBL] [Abstract][Full Text] [Related]
3. In vitro permeability of a model protein across ocular tissues and effect of iontophoresis on the transscleral delivery.
Tratta E; Pescina S; Padula C; Santi P; Nicoli S
Eur J Pharm Biopharm; 2014 Sep; 88(1):116-22. PubMed ID: 24816128
[TBL] [Abstract][Full Text] [Related]
4. Examination of penetration routes and distribution of ionic permeants during and after transscleral iontophoresis with magnetic resonance imaging.
Molokhia SA; Jeong EK; Higuchi WI; Li SK
Int J Pharm; 2007 Apr; 335(1-2):46-53. PubMed ID: 17236728
[TBL] [Abstract][Full Text] [Related]
5. Enhanced transscleral lontophoretic transport with ion-exchange membrane.
Li SK; Zhu H; Higuchi WI
Pharm Res; 2006 Aug; 23(8):1857-67. PubMed ID: 16841198
[TBL] [Abstract][Full Text] [Related]
6. Iontophoretic transport of charged macromolecules across human sclera.
Chopra P; Hao J; Li SK
Int J Pharm; 2010 Mar; 388(1-2):107-13. PubMed ID: 20045044
[TBL] [Abstract][Full Text] [Related]
7. In vitro optimization of dexamethasone phosphate delivery by iontophoresis.
Sylvestre JP; Guy RH; Delgado-Charro MB
Phys Ther; 2008 Oct; 88(10):1177-85. PubMed ID: 18719003
[TBL] [Abstract][Full Text] [Related]
8. Transscleral passive and iontophoretic transport: theory and analysis.
Li SK; Hao J
Expert Opin Drug Deliv; 2018 Mar; 15(3):283-299. PubMed ID: 29149574
[TBL] [Abstract][Full Text] [Related]
9. Transcorneal and transscleral iontophoresis of dexamethasone phosphate using drug loaded hydrogel.
Eljarrat-Binstock E; Raiskup F; Frucht-Pery J; Domb AJ
J Control Release; 2005 Sep; 106(3):386-90. PubMed ID: 16026884
[TBL] [Abstract][Full Text] [Related]
10. Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: effect of experimental parameters and skin type on drug stability and transport kinetics.
Cázares-Delgadillo J; Balaguer-Fernández C; Calatayud-Pascual A; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
Eur J Pharm Biopharm; 2010 Jun; 75(2):173-8. PubMed ID: 20332024
[TBL] [Abstract][Full Text] [Related]
11. Transdermal and intradermal iontophoretic delivery of dexamethasone sodium phosphate: quantification of the drug localized in skin.
Paturi J; Kim HD; Chakraborty B; Friden PM; Banga AK
J Drug Target; 2010 Feb; 18(2):134-40. PubMed ID: 19772394
[TBL] [Abstract][Full Text] [Related]
12. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
[TBL] [Abstract][Full Text] [Related]
13. In vitro trans-scleral iontophoresis of methylprednisolone hemisuccinate with short application time and high drug concentration.
Pescina S; Martini D; Santi P; Padula C; Murtomäki L; Nicoli S
Int J Pharm; 2013 Jul; 451(1-2):12-7. PubMed ID: 23628405
[TBL] [Abstract][Full Text] [Related]
14. Trans-scleral iontophoretic delivery of low molecular weight therapeutics.
Güngör S; Delgado-Charro MB; Ruiz-Perez B; Schubert W; Isom P; Moslemy P; Patane MA; Guy RH
J Control Release; 2010 Oct; 147(2):225-31. PubMed ID: 20655965
[TBL] [Abstract][Full Text] [Related]
15. In vitro sustained human transscleral drug delivery of fluorescein-labeled dexamethasone and methotrexate with fibrin sealant.
Cruysberg LP; Nuijts RM; Gilbert JA; Geroski DH; Hendrikse F; Edelhauser HF
Curr Eye Res; 2005 Aug; 30(8):653-60. PubMed ID: 16109645
[TBL] [Abstract][Full Text] [Related]
16. [Transcorneal and transscleral iontophoresis of the dexamethasone phosphate into the rabbit eye].
Raiskup-Wolf F; Eljarrat-Binstock E; Rehák M; Domb A; Frucht-Pery J
Cesk Slov Oftalmol; 2007 Sep; 63(5):360-8. PubMed ID: 17915587
[TBL] [Abstract][Full Text] [Related]
17. Examination of barriers and barrier alteration in transscleral iontophoresis.
Molokhia SA; Jeong EK; Higuchi WI; Li SK
J Pharm Sci; 2008 Feb; 97(2):831-44. PubMed ID: 17879296
[TBL] [Abstract][Full Text] [Related]
18. Novel dexamethasone-loaded nanomicelles for the intermediate and posterior segment uveitis.
Vaishya RD; Gokulgandhi M; Patel S; Minocha M; Mitra AK
AAPS PharmSciTech; 2014 Oct; 15(5):1238-51. PubMed ID: 24895075
[TBL] [Abstract][Full Text] [Related]
19. Effect of formulation factors on the trans-scleral iontophoretic and post-iontophoretic transports of a 40 kDa dextran in vitro.
Pescina S; Padula C; Santi P; Nicoli S
Eur J Pharm Sci; 2011 Apr; 42(5):503-8. PubMed ID: 21352911
[TBL] [Abstract][Full Text] [Related]
20. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
